Sign In

Mike Dybbs

at Samsara BioCapital

Mike Dybbs is a Partner at Samsara BioCapital, a venture capital firm specializing in life sciences investments. He has been with Samsara since its inception in 2017 and serves on the boards of several portfolio companies, including Delfi Diagnostics, Enara Bio, Fluent, Ionpath, Nkarta Therapeutics, and Sutro Biopharma.15

Background and Education

  • Education: Mike Dybbs holds an A.B. in Biochemical Sciences from Harvard University and a PhD in Molecular Biology from the University of California, Berkeley, where he was awarded a Howard Hughes Medical Institute fellowship.12
  • Research: His research has been published in prestigious journals such as Nature, Science, and Neuron.12

Career

  • Samsara BioCapital: Partner since 2017, focusing on investments across the life sciences sector.15
  • New Leaf Venture Partners: Previously a Partner from 2009 to 2016, serving on boards of companies like Versartis, Dimension Therapeutics, and Principia.13
  • The Boston Consulting Group: Principal from 2005 to 2009, specializing in healthcare strategy.13

LinkedIn Profile

Mike Dybbs' LinkedIn username is mike-dybbs-865452a, and he is based in Burlingame, California.4 His profile highlights his extensive experience in the biopharmaceutical industry and his roles in various venture capital and biotech companies.

Related Questions

What are some of the key companies Mike Dybbs has invested in at Samsara BioCapital?
How did Mike Dybbs' experience at the Boston Consulting Group influence his career in biotech?
What are Mike Dybbs' main responsibilities as a Partner at Samsara BioCapital?
Can you provide more details about the companies Mike Dybbs served on the boards of at New Leaf Venture Partners?
What are some notable achievements or milestones in Mike Dybbs' career?
Mike Dybbs
Mike Dybbs, photo 1
Mike Dybbs, photo 2
Add to my network

Location

Burlingame, California